Covagen Secures CHF 42 Million in Series B Financing
Covagen today announced that the company has secured CHF 42 million in a tranched Series B financing with an option to o…
Covagen today announced that the company has secured CHF 42 million in a tranched Series B financing with an option to o…
Gimv today announced that St.Jude Medical (www.sjm.com) acquired portfolio company Endosense (Switzerland). Under the te…
Gimv and Gimv managed Biotech Fonds Vlaanderen invest in Complix, a biopharmaceutical company focused on the discovery a…